BIO Financials
Bio-Rad Laboratories Inc - Financial statements & key metrics
Stock Price
$278.44
Market Cap
$7.52B
P/E Ratio
10.0
EPS
$27.85
Income Statement Highlights
Most Recent Quarter: 2025-12-31
Revenue
$2.58B
Gross Profit
$1.34B
Operating Income
$270.50M
Net Income
$759.90M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$10.58B
Total Liabilities
$3.12B
Shareholders Equity
$7.45B
Cash & Equivalents
$531.80M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$532.20M
CapEx
$157.60M
Free Cash Flow
$374.60M
Profitability Metrics
Gross Margin
52.0%
Operating Margin
0.1%
Net Margin
0.3%
ROE
0.1%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is BIO revenue?
BIO's most recent quarterly revenue was $2.58B. Annual revenue can be calculated by summing the four most recent quarters.
Is BIO profitable?
BIO reported a profit of $759.90M in the most recent quarter. The net profit margin is 0.3%.
What is BIO market cap?
BIO has a market capitalization of $7.52B, making it a mid-cap stock.
Does BIO have debt?
View BIO's balance sheet for debt information.
What is BIO cash flow?
BIO's most recent quarterly free cash flow was $374.60M.